Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.62
Delayed Data
As of Aug 31
 -0.23 / -3.93%
Today’s Change
3.71
Today|||52-Week Range
10.15
+23.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization28.3K14.7K5.4K6.0K
 
 
 
 
 
 
Operating ExpensesGross Income-28.3K-14.7K-5.4K-6.0K
 
 
 
 
 
General Expenses2.4M2.9M4.3M6.3M
 
 
 
 
 
Research And Development1.1M1.7M2.3M3.7M
 
 
 
 
 
Total Operating Expenses2.4M2.9M4.3M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-2.9M-4.3M-6.3M
 
 
 
 
 
Extraordinary Credit0.000.0044.7K--
 
 
Extraordinary Charge-197.4K-184.3K----
 
 
 
Other Expenses1.0M-199.1K-196.4K504.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-3.3M-4.4M-5.7M
 
 
 
 
 
Income Taxes-24.0K-90.2K-205.1K-4.0K
 
 
 
 
 
Net Income-1.6M-3.3M-4.2M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.4M5.9M7.2M9.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.4M5.9M7.2M9.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.60-$0.59-$0.62
 
 
 
 
 
EPS Diluted-$0.24-$0.60-$0.59-$0.62